annb0t
Top 20
West Pharmaceutical Services, Inc. WST delivered adjusted earnings per share (EPS) of $1.82 in the fourth quarter of 2024, down by a penny year over year. The figure topped the Zacks Consensus Estimate by 4%.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The adjustments include expenses related to amortization of acquisition-related intangible assets, among others.
GAAP EPS for the quarter was $1.78, reflecting a decline of 2.7% from the year-ago figure.
Full-year 2...
>>> Read more: WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The adjustments include expenses related to amortization of acquisition-related intangible assets, among others.
GAAP EPS for the quarter was $1.78, reflecting a decline of 2.7% from the year-ago figure.
Full-year 2...
>>> Read more: WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down
